Analysis
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000-2016
Purpose:
Disparities in breast cancer survival have been observed within marginalized racial/ethnic groups and within the rural-urba...
New Study in JNCCN Presents Evidence for 'Tough Conversations' Around Racism in Access to Cancer Care
New study in JNCCN presents evidence for ‘tough conversations’ around racism in access to cancer Care
Research led by Duke University School of Med...
African American Alzheimer's Caregiver Training and Support Project 2 (ACTS2) pilot study: Outcomes analysis
Purpose/objective:
The purpose of this study was to conduct an initial evaluation of the quantitative and qualitative outcomes of th...
Pancreatic cancer among Pacific Islanders: a comprehensive analysis of an understudied racial group
Objective:
Racial disparities in care and outcome have been demonstrated for several cancers, but it is not clear that a similar dis...
Monkeypox is disproportionately affecting Black, Hispanic people, latest CDC breakdown shows
A detailed analysis of monkeypox case records published by the US Centers for Disease Control and Prevention on Friday offers new insight into the ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
